Clinical Trial Update: Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing long-term safety of bimatoprost ophthalmic solution in glaucoma or ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Bimatoprost ophthalmic solution (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2018-09-17